Koninklijke Philips (NYSE:PHG) Shares Purchased by Ballentine Partners LLC

Ballentine Partners LLC boosted its holdings in Koninklijke Philips (NYSE:PHG) by 20.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,492 shares of the technology company’s stock after acquiring an additional 1,783 shares during the quarter. Ballentine Partners LLC’s holdings in Koninklijke Philips were worth $343,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in PHG. Wealth Enhancement Advisory Services LLC increased its position in Koninklijke Philips by 6.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 60,365 shares of the technology company’s stock valued at $1,207,000 after acquiring an additional 3,891 shares during the period. Allspring Global Investments Holdings LLC bought a new position in Koninklijke Philips during the 1st quarter valued at $40,000. DB Fitzpatrick & Co Inc boosted its stake in Koninklijke Philips by 25.0% during the 1st quarter. DB Fitzpatrick & Co Inc now owns 80,411 shares of the technology company’s stock valued at $1,608,000 after purchasing an additional 16,084 shares in the last quarter. Legacy Wealth Asset Management LLC boosted its stake in Koninklijke Philips by 3.5% during the 1st quarter. Legacy Wealth Asset Management LLC now owns 56,271 shares of the technology company’s stock valued at $1,125,000 after purchasing an additional 1,880 shares in the last quarter. Finally, Commonwealth Equity Services LLC boosted its stake in Koninklijke Philips by 6.1% during the 1st quarter. Commonwealth Equity Services LLC now owns 55,409 shares of the technology company’s stock valued at $1,108,000 after purchasing an additional 3,182 shares in the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Koninklijke Philips currently has an average rating of “Hold”.

Koninklijke Philips Stock Performance

PHG opened at $26.62 on Tuesday. The firm has a market cap of $25.02 billion, a PE ratio of -50.23, a P/E/G ratio of 1.04 and a beta of 0.74. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. The business has a fifty day simple moving average of $31.05 and a 200-day simple moving average of $27.83. Koninklijke Philips has a fifty-two week low of $18.47 and a fifty-two week high of $32.91.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. The business had revenue of $4.80 billion during the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. As a group, equities analysts predict that Koninklijke Philips will post 1.59 EPS for the current fiscal year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.